Research graph
References from Trends in Hepatitis D Virus Prevalence Among HBsAg‐Positive Individuals With and Without HIV in Italy: A Converging Epidemiology. Local targets link to admitted publications; unresolved targets remain external evidence.
Hepatitis D: A Review
10.1001/jama.2023.23242 · 2023 · External reference
Hepatitis D Virus Infection: Pathophysiology, Epidemiology and Treatment. Report From the Third Delta Cure Meeting 2024
10.1111/liv.70189 · 2025 · External reference
Hepatitis Delta Infection Among Persons Living With HIV in Europe
10.1111/liv.15519 · 2023 · External reference
Determinants of Worse Liver‐Related Outcome According to HDV Infection Among HBsAg Positive Persons Living With HIV: Data From the ICONA Cohort
10.1111/liv.15804 · 2024 · External reference
Epidemiology of Hepatitis D Virus Infection in Europe: Is It Vanishing?
10.1111/jvh.13899 · 2024 · External reference
Insight Into the Reasons for Discontinuation of the First Highly Active Antiretroviral Therapy (HAART) Regimen in a Cohort of Antiretroviral naïve Patients
10.1097/00002030-200003310-00005 · 2000 · External reference
The Present Profile of Chronic Hepatitis B Virus Infection Highlights Future Challenges: An Analysis of the Multicenter Italian MASTER‐B Cohort
10.1016/j.dld.2018.09.008 · 2019 · External reference
A Holistic Evaluation of Patients With Chronic Hepatitis D Virus (HDV) Infection Enrolled in the Italian PITER‐B and Delta Cohort
10.1016/j.ijid.2024.107115 · 2024 · External reference
Demographic and Socio‐Economic Determinants of Poor HIV‐Risk Perception at First HIV Diagnosis: Analysis of the HIV Surveillance Data, Italy 2010‐2016
2020 · External reference
The Impact of Needle and Syringe Exchange Programs on HIV‐Related Risk Behaviors in Low‐ and Middle‐Income Countries: A Systematic Review and Meta‐Analysis Examining Individual‐ Versus Community‐Level Effects
10.1007/s10461-023-04051-x · 2023 · External reference
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm
10.1111/liv.70242 · 2025 · External reference
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV‐Coinfected Patients
10.1097/qai.0000000000002589 · 2021 · External reference
Bictegravir, Emtricitabine, and Tenofovir Alafenamide Versus Dolutegravir, Emtricitabine, and Tenofovir Disoproxil Fumarate for Initial Treatment of HIV‐1 and Hepatitis B Coinfection (ALLIANCE): A Double‐Blind, Multicentre, Randomised Controlled, Phase 3 Non‐Inferiority Trial
10.1016/s2352-3018(23)00151-0 · 2023 · External reference
Hepatitis Delta‐Associated Mortality in HIV/HBV‐Coinfected Patients
10.1016/j.jhep.2016.10.007 · 2017 · External reference
Reducing Rates of Preventable HIV/AIDS‐Associated Mortality Among People Living With HIV Who Inject Drugs
10.1097/coh.0000000000000297 · 2016 · External reference
